Lupin targets GSK's Advair; Drugmakers often violate marketing codes;

@FiercePharma: ICYMI earlier: Pharma's top 10 deals of 2014. Feature | Follow @FiercePharma

@CarlyHFierce: Pharma wanted pricey orphan meds, and now it's got 'em in record numbers. Story | Follow @CarlyHFierce

> Indian drugmaker Lupin is launching a new inhaler in the U.S. while also working on a generic version of GlaxoSmithKline's ($GSK) Advair Diskus. Story

> A study finds that drugmakers often violate voluntary marketing codes in the U.K. and Sweden. Report

> Will Apotex's FDA quality entanglements affect its chances of getting a biosimilar of Amgen's ($AMGN) Neupogen approved in the U.S.? Blog

Medical Device News

@FierceMedDev: Lineagen reels in $19.8M in Series C round for autism genetic tests. Story | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Vagus nerve stimulation, other forms of bioelectric medicine on cover of Scientific American. Item | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Boston Scientific hands over $600M to settle breach-of-contract Guidant suit with J&J. Article | Follow @EmilyWFierce

> GE recalls 10,000+ MRIs after FDA deems them potentially deadly, citing poor training. News

> Mayo Clinic joins $20.5M Series A reboot for next-gen sequencing startup Lifecode. Story

> FDA panel considering PMA application of spinal implant due to fractures. Article

Biotech News

@FierceBiotech: Lilly delays its high-risk 'good' cholesterol trial with IMPROVE-IT in mind. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI yesterday: Star scientist Peter Mueller gets $28M war chest to advance R&D at Pronutria. Article | Follow @JohnCFierce

@DamianFierce: Someone needs to talk to Mark Levin about this sweater situation. More | Follow @DamianFierce

> Roche and Exelixis roll toward FDA approval with a melanoma cocktail. More

> Kite dives into manufacturing amid CAR-T frenzy. Story

> Novartis leads a $28M round for rare disease biotech Merganser. Article

Vaccines News

> Advaxis nets $23M in financing for cancer vaccine development. More

> Protein Sciences halts Connecticut expansion in response to governor's use of rival flu shot. News

> Novavax's Ebola vaccine is in hot pursuit of GSK, Merck, J&J candidates. Story

> VaxInnate reaps $53M for flu jab trials on BARDA contract extension. Article

> Gates Foundation, WHO fund synthetic polio vaccine development. Report

Pharma Manufacturing News

> Taro recalls nearly 37,000 bottles of children's allergy relief syrup. Article

> WuXi inks deal to borrow $165M to support manufacturing growth. News

> InvaGen Pharma and AlphaMed Bottles building new plants on Long Island. Story

> Protein Sciences cancels expansion plans after governor gets flu shot from foreign competitor. Item

> India mulling plans to build bulk drug manufacturing capacity. Report